In mice, Wang et al. (17), have also demonstrated that the deficiency of PSGL-1 on plasma cells may attenuate angiotensin-II-induced hypertension, and their findings suggest that this is potentially mediated by the reduced levels of IL-17 observed in PSGL-1−/− mice. Here, SELPLG is linked to hypertensive disorder.